Anti-CD20

3 Drugs classified under this drug class

Anti-CD20, Monoclonal Antibody. Ocrelizumab 300 mg / 10 ml.
VIAL: 1×10ml. 300 mg IV  infus., follow.  two wks. later by a 2^ND 300 mg IV infus. Subseq. doses: single 600 mg IV infus.  every 6 mnths. See lit.
Tmt. of adult pts. with relaps. or primary progres. forms of multiple sclerosis.
C/I: Hypersens. Active HBV infec. A history of life-threatening infus. reaction to Ocrelizumab.

Anti-CD20, Human Monoclonal Antibody. Ocrelizumab 40 mg/ml.
Vial. 1 X 920 mg for SC inject.
single 23 mL in the abdomen over approx. 10 minutes every 6 months.
For adults with relapsing or primary progress. forms of multiple sclerosis.
C/I:Hypersens. Active HBV infection/ A hist. of life-threatening admin. reaction to ocrelizumab

Anti-CD20, anti-CD3. Epcoritamab 5 mg/ml, 60 mg/ml.
Vial, Sol. for inj. 1 X 4 mg/0.8 ml or 48 mg
To be admin in cycles of 28 days as per full prescription info. Pre-medication needed.
For adults with relapsed or refractory diffuse large B-cell
lymphoma (DLBCL), not otherwise specified, including DLBCL arising from indolent lymphoma, and high grade B cell lymphoma after two or more lines of syst. ther.
As monother. for adults with relapsed or refractory follicular
lymphoma (FL) after two or more lines of syst. ther/
C/I:  Hypersens.